Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 86Breast Neoplasms 70Prostatic Neoplasms 34Head and Neck Neoplasms 26Lung Neoplasms 24Colorectal Neoplasms 24Ovarian Neoplasms 22Uterine Cervical Neoplasms 21Endometrial Neoplasms 16Brain Neoplasms 15Rectal Neoplasms 12Pancreatic Neoplasms 11Colonic Neoplasms 11Urinary Bladder Neoplasms 9Melanoma 9Lymphoma 9Leukemia 9Depression 9Stomach Neoplasms 8Pain 8Motor Activity 8Colorectal Neoplasms, Hereditary Nonpolyposis 8Sarcoma 7Oropharyngeal Neoplasms 7Multiple Myeloma 7Hematologic Neoplasms 7COVID-19 7Vulvar Neoplasms 6Health Behavior 6Glioma 6

Interventions

Surveys and Questionnaires 1Restraint, Physical 1Apolipoproteins E 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Breast Cancer Survivors × Surveys and Questionnaires × Clear all
NCT02753985 2019-07-23

Adherence to Aromatase Inhibitors: The Role of Partners

Abramson Cancer Center at Penn Medicine

Completed
40 enrolled
Breast

Breast Cancer Survivors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡